Suggestions
Sona Chandra
President - AI, Pangea Bio | Harvard | Forbes 30 under 30
Sona Chandra is the President and Co-founder of AI at Pangea Bio, a role she has held since August 2022. She is recognized for her efforts in harnessing data and artificial intelligence to enhance therapeutic solutions, aiming to improve global health outcomes. Chandra has a background in Biomedical Engineering and has accumulated extensive experience in the medical device and pharmaceutical sectors.
Professional Background
-
Pangea Bio: As President and Co-founder, she focuses on integrating AI into biopharmaceuticals to unlock the potential of nature's resources for therapeutic use.
-
Terra Lumina: Prior to Pangea Bio, she founded Terra Lumina, which was acquired by Pangea in 2022.
-
Oshi Health: Chandra has held multiple roles, including Head of Clinical Strategy & Operations and Co-Founder/Product Manager, contributing to the company's strategic direction in healthcare.
-
Takeda: She worked as an Integrated Healthcare Solution Engineer and Digital Engineer, gaining valuable experience in the pharmaceutical industry.
Education
Sona Chandra studied Biomedical Engineering and has participated in various educational programs, including a study abroad program at the University of Limerick.
Recognition
She was named in the Forbes 30 Under 30 list in the Science & Healthcare category, highlighting her influence and contributions to the field at a young age.1
